<DOC>
	<DOCNO>NCT01178853</DOCNO>
	<brief_summary>This Phase 4 , single center , open label , 4 period , 2 treatment , crossover , drug-drug interaction study .</brief_summary>
	<brief_title>Drug-Drug Interaction Study Assess Effects Steady State Pitavastatin 4 mg Rosuvastatin 40 mg Steady-State Warfarin Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Subject healthy adult male female volunteer age 18 45 year , inclusive Subject body mass index 18 32 kg/m2 , inclusive Subject able willing abstain alcohol , grapefruit , caffeine Subject clinically relevant abnormality basis medical history , physical examination , vital sign Subject clinically relevant outofrange prothrombin time ( PT ) , activate partial thromboplastin time , fibrinogen , protein C , protein S Subject abnormal prolongation bleeding time Screening Subject hematuria urinalysis Subject personal family history coagulation bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>